We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
(+17%)
Cap. Flow
+$74.9M
Cap. Flow
% of AUM
13.41%
Top 10 Holdings %
Top 10 Hldgs %
4.09%
Holding
1,998
New
778
Increased
301
Reduced
272
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.2M |
| 2 |
Boeing
BA
|
+$2.64M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.42M |
| 4 |
Amgen
AMGN
|
+$2.03M |
| 5 |
Elevance Health
ELV
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.64M |
| 2 |
Lockheed Martin
LMT
|
+$2.31M |
| 3 |
Cigna
CI
|
+$2.21M |
| 4 |
Wells Fargo
WFC
|
+$2.18M |
| 5 |
Paychex
PAYX
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Discretionary | 14.34% |
| 4 | Industrials | 14.21% |
| 5 | Financials | 12.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Comstock
LODE
$236M
| $25.9K | ﹤0.01% |
+3,543
| New | +$22K |
|
1302
The Honest Company
HNST
$423M
| $25.5K | ﹤0.01% |
+15,187
| New | +$25.9K |
|
|
SDC
1303
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $25K | ﹤0.01% |
+47,160
| New | +$19.2K |
|
|
MAPS
1304
DELISTED
WM TECHNOLOGY INC A
MAPS
| $24.6K | ﹤0.01% |
+29,385
| New | +$24K |
|
|
ASTR
1305
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $24.5K | ﹤0.01% |
+4,439
| New | +$25.4K |
|
|
EFTR
1306
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $23.9K | ﹤0.01% |
+1,153
| New | +$19.5K |
|
1307
NN Inc
NNBR
$273M
| $23.9K | ﹤0.01% |
+10,010
| New | +$15.2K |
|
1308
SOBR Safe
SOBR
$1.75M
| $23.6K | ﹤0.01% |
13
-6
| -32% | -$12.2K |
|
|
BGXX
1309
DELISTED
Bright Green Corporation Common Stock
BGXX
| $23.6K | ﹤0.01% |
+23,357
| New | +$25.3K |
|
1310
Vroom Inc
VRM
$37.5M
| $23.2K | ﹤0.01% |
201
-1,289
| -87% | -$98.2K |
|
|
AMTD
1311
AMTD IDEA Group
AMTD
$72.8M
| $22.9K | ﹤0.01% |
+4,821
| New | +$23.6K |
|
|
DWTX
1312
Dogwood Therapeutics
DWTX
$51.5M
| $22.7K | ﹤0.01% |
+657
| New | +$18.7K |
|
1313
Fuel Tech
FTEK
$47.4M
| $22.2K | ﹤0.01% |
+16,748
| New | +$21.9K |
|
1314
Arqit Quantum
ARQQ
$316M
| $22.1K | ﹤0.01% |
+732
| New | +$22.1K |
|
1315
Absci
ABSI
$1.28B
| $21.3K | ﹤0.01% |
14,026
+938
| +7% | +$1.51K |
|
1316
Phunware
PHUN
$43.1M
| $21K | ﹤0.01% |
+777
| New | +$23.8K |
|
1317
Praxis Precision Medicines
PRAX
$8.8B
| $20.9K | ﹤0.01% |
+1,209
| New | +$18.5K |
|
1318
TOP Ships
TOPS
$4.33M
| $20.6K | ﹤0.01% |
+2,997
| New | +$26.3K |
|
1319
Dianthus Therapeutics
DNTH
$5.71B
| $20.4K | ﹤0.01% |
+1,683
| New | +$19.1K |
|
|
CISO
1320
CISO Global
CISO
$11.5M
| $20.1K | ﹤0.01% |
+7,516
| New | +$25K |
|
|
HLGN
1321
DELISTED
Heliogen, Inc.
HLGN
| $19.8K | ﹤0.01% |
+2,310
| New | +$21.2K |
|
1322
Denison Mines
DNN
$2.64B
| $18.9K | ﹤0.01% |
+15,124
| New | +$16.8K |
|
1323
Unicycive Therapeutics
UNCY
$141M
| $18.5K | ﹤0.01% |
+1,446
| New | +$22.6K |
|
1324
Bolt Biotherapeutics
BOLT
$7.64M
| $17K | ﹤0.01% |
+665
| New | +$21.1K |
|
|
DUO
1325
Fangdd Network Group
DUO
$23.4M
| $16.4K | ﹤0.01% |
+78
| New | +$16.5K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2023 Portfolio in Review
As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.
XTX Topco deployed $74.9M of net new capital in Q2 2023, opening 778 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.
- XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
- XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
- XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
- XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
- XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
- XTX Topco opened 778 new positions and closed 643 in Q2 2023.
- XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.
Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.